Evidence for a complex risk profile in obese postmenopausal Turkish women with hypertriglyceridaemia and elevated apolipoprotein B

Clinical Science

Volumn 107, Issue 1, 2004, Pages 97-104

  Onat, Altan ^a   Yazici, Mehmet ^b   Can, Günay ^a   Sniderman, Allan ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Apolipoprotein B(apoB); Coronary disease risk; Obesity; Risk profile; Sex hormone

Indexed keywords

APOLIPOPROTEIN B; COMPLEMENT COMPONENT C3; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

AGED; ANTHROPOMETRY; APOLIPOPROTEINS B; BODY CONSTITUTION; CORONARY DISEASE; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYPERTRIGLYCERIDEMIA; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 3142699163     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040021     Document Type: Article

References (42)

1. Forbes, G. B. (1999) Body composition: influence of nutrition, disease, growth, and aging. Modern Nutrition in Health and Disease, 9th edn. (Shils, M. E., Olson, J. A., Shike, E. and Ross, A. C., eds.), pp. 789-809, Lippincott, Williams & Wilkins, Baltimore
2. MacLean, D. R., Petrasovits, A., Connelly, P. W., Joffres, M., O'Connor, B. and Little, J. A. (1999) Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group. Can. J. Cardiol. 15, 434-444
3. Connelly, P. W., Poapst, M., Davignon, J. et al. (1999) Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group. Can. J. Cardiol. 15, 409-418
4. Contois, J. H., McNamara, J. R., Lammi-Keefe, C. J., Wilson, P. W., Massov, T. and Schaefer, E. J. (1996) Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin. Chem. 42, 515-523
5. Sniderman, A., Cianflone, K., Arner, P., Summers, L. K. and Frayn, K. N. (1998) The adipocyte, fatty acid trapping, and atherogenesis. Arterioscler., Thromb., Vasc. Biol. 18, 147-151
6. Wajchenberg, B. L. (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21, 697-738
7. Onat, A. and Şenocak, M. (1994) Relative risk of factors for coronary heart disese in population with low cholesterol levels. Int. J. Cardiol. 43, 51-60
8. Onat, A. (2001) Risk factors and cardiovascular disease in Turkey. Atherosclerosis 156, 1-10
9. Sniderman, A. D., Scantlebury, T. and Cianflone, K. (2001) Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann. Intern. Med. 135, 447-459
10. Sniderman, A. D., Wolfson, C., Teng, B., Franklin, F. A., Bachorik, P. S. and Kwiterovich, Jr, P. O. (1982) Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann. Intern. Med. 97, 833-839
11. Mahley, R. W., Palaoǧlu, E., Atak, Z. et al. (1995) Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J. Lipid Res. 36, 839-859
12. Onat, A., Ceyhan, K., Sansoy, V. et al. (2002) Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women. Int. J. Cardiol. 86, 61-69
13. Lamarche, B., Moorjani, S., Lupien, P. J. et al. (1996) Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec Cardiovascular Study. Circulation 94, 273-278
14. Walldius, B., Jungner, I., Holme, I., Aastveit, A. H., Kolar, W. and Steiner, E. (2001) High apolipoprotein B, low apolipoprotein A-I and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358, 2026-2033
15. Rose, G., Blackburn, H., Gillum, R. F. and Prineas, R. J. (1982) Cardiovascular Survey Methods, 2nd edn, World Health Organisation, Geneva
16. Onat, A. (2002) A proposed scoring scheme for assessing coronary risk in Turkish adults (in Turkish, summary in English). Arch. Turk. Soc. Cardiol. 30, 604-611
17. Tchernof, A. and Despres, J. P. (2000) Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm. Metab. Res. 32, 526-536
18. Haffner, S. M., Katz, M. S., Stern, M. P. and Dunn, J. F. (1989) Association of decreased sex hormone binding globulin and cardiovascular risk factors. Arteriosclerosis 9, 136-143
19. Haffner, S. M., Dunn, J. F. and Katz, M. S. (1992) Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 41, 278-284
20. Korhonen, S., Hippelainen, M., Vanhala, M. et al. (2003) The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study. Fertil. Steril. 79, 1327-1334
21. Reinecke, H., Bogdanski, J., Woltering, A. et al (2002) Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am. J. Cardiol. 90, 364-368
22. Van Pottelbergh, I., Braeckman, L., De Bacquer, D., De Backer, G. and Kaufman, J. M. (2003) Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. Atherosclerosis 166, 95-102
23. Despres, J. P. (2001) Health consequences of visceral obesity. Ann. Med. 33, 534-541
24. Libby, P., Ridker, P. M. and Maseri, A. (2002) Inflammation and atherosclerosis. Circulation. 105, 1135-1143
25. Willerson, J. T. (2002) Systemic and local inflammation in patients with unstable atherosclerotic plaques. Prog. Cardiovas. Dis. 44, 469-478
26. Onat, A., Sansoy, V., Yildirim, B., Keleş, I., Uysal, Ö. and Hergenç, G. (2001) C-reactive protein and coronary heart disease in Western Turkey. Am. J. Cardiol. 88, 601-607
27. Williams, K., Sniderman, A. D., Sattar, N., D'Agostino, Jr, R., Wagneknecht, L. and Haffner, S. M. (2003) Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 108, 2312-2316
28. Muscari, A., Massarelli, G., Bastagli, L. et al. (2001) Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur. Heart J. 21, 1081-1090
29. Muscari, A., Massarelli, G., Bastagli, L. et al. (1998) Relationship between serum C3 levels and traditional risk factors for myocardial infarction. Acta Cardiol. 53, 345-354
30. Halkes, C. J. M. V. D. H., De Jaegere, P. P. Th., Plokker, H. M. V., Van der Helm, Y., Erkelens, D. W. and Castro Cabezas, M. (2001) Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease. Effects of expanded dose simvastatin. Arterioscler., Thromb., Vasc. Biol. 21, 1526-1530
31. Meijssen, S., van Dijk, H., Verseyden, C., Erkelens, D. W. and Cabezas, M. C. (2002) Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Arterioscler., Thromb., Vasc. Biol. 22, 811-816
32. Ylitalo, K., Pajukanta, P., Meri, S. et al. (2001) Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia. Arterioscler., Thromb., Vasc. Biol. 21, 838-843
33. Xia, Z. and Cianflone, K. (2003) Acylation-stimulating protein precursor proteins in adipose tissue in human obesity. Metab., Clin. Exp. 52, 1360-1366
34. Faraj, M., Sniderman, A. and Cianflone, K. (2004) ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J. Lipid Res. 45, 657-666
35. Haffner, S. M., Stern, M. P., Hazuda, H. P., Mitchell, B. D., Patterson, J. K. and Ferrannini, E. (1989) Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis 9, 928-933
36. Lamarche, B., Tchernof, A., Mauriege, P. et al. (1998) Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. J. Am. Med. Assoc. 279, 1955-1961
37. Schumacher, M. C., Maxwell, T. M., Wu, L. L., Hunt, S. C., Williams, R. R. and Elbein, S. C. (1992) Dyslipidemias among normoglycemic members of familial NIDDM pedigrees. Diabetes Care 15, 1285-1289
38. Ballantyne, C. M., Olsson, A. G., Cook, T. J., Mercuri, M. F., Pedersen, T. R. and Kjekshus, J. (2001) Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation 104, 3046-3051
39. Moss, A. J., Goldstein, R. E., Marder, V. J. et al. (1999) Thrombogenic factors and recurrent coronary events. Circulation 99, 2517-2522
40. Gotto, Jr, A. M., Whitney, E., Stein, E. A. et al. (2000) Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Circulation 101, 477-484
41. Pedersen, T. R., Olsson, A. G., Faergeman, O., Kjekshus, J., Wedel, H. and Berg, K. (1998) Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 97, 1453-1460
42. Simes, R. J., Marschner, I. C., Hunt, D. et al. (2002) Relationship between lipid levels and clinical outcomes in LIPID. To what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? Circulation 105, 1162-1169